Literature DB >> 31001932

YWHAE promotes proliferation, metastasis, and chemoresistance in breast cancer cells.

Yi-Fang Yang1, Yi-Chen Lee2, Yen-Yun Wang3, Chie-Hong Wang4, Ming-Feng Hou5,6,7, Shyng-Shiou F Yuan1,8,9.   

Abstract

Breast cancer is the most common female-specific malignancy in Taiwan and developed countries worldwide, and its incidence continues to grow. 14-3-3ε (YWHAE), which belong to 14-3-3 family, it has been reported up-regulated in breast cancer tissues. However, the clinical implication and function of YWHAE in breast cancer remains unclear. In this study, we investigated the prognostic value of the YWHAE in human breast cancer. Immunohistochemistry was used to analyze YWHAE expression in breast cancer tissues. Cell model was applied to examine the functions of YWHAE. The chemotherapeutic agents were used to evaluate the effect of YWHAE in breast cancer cell lines. YWHAE expression was associated with tumor size, lymph node metastasis, and poor patient survival in patients with breast cancer. YWHAE overexpression significantly increased the proliferation, migration, and invasion abilities of breast cancer cells. Knockdown of YWHAE expression reduced the expression of Snail and Twist in breast cancer cells. We also found that YWHAE was responsible for the resistance of breast cancer cells to chemotherapeutic agents, and knockdown of YWHAE enhanced sensitivity to multiple chemotherapeutic agents in breast cancer cells. Taken together, our findings indicated that YWHAE promoted cancer progression and chemoresistance in breast cancer cells and can be a potential therapeutic target for breast cancer.
© 2019 The Authors. The Kaohsiung Journal of Medical Sciences published by John Wiley & Sons Australia on behalf of Kaohsiung Medical University.

Entities:  

Keywords:  14-3-3ε; YWHAE; breast cancer; chemoresistance

Mesh:

Substances:

Year:  2019        PMID: 31001932     DOI: 10.1002/kjm2.12075

Source DB:  PubMed          Journal:  Kaohsiung J Med Sci        ISSN: 1607-551X            Impact factor:   2.744


  10 in total

Review 1.  LG-ESSs and HG-ESSs: underlying molecular alterations and potential therapeutic strategies.

Authors:  Chunhui Li; Chunhong Wang
Journal:  J Zhejiang Univ Sci B       Date:  2021-08-15       Impact factor: 3.066

2.  miR-31-5p Regulates 14-3-3 ɛ to Inhibit Prostate Cancer 22RV1 Cell Survival and Proliferation via PI3K/AKT/Bcl-2 Signaling Pathway.

Authors:  Jiafu Zhao; Houqiang Xu; Zhiqiang Duan; Xiang Chen; Zheng Ao; Yinglian Chen; Yong Ruan; Mengmeng Ni
Journal:  Cancer Manag Res       Date:  2020-07-31       Impact factor: 3.989

3.  YWHAE as an HE4 interacting protein can influence the malignant behaviour of ovarian cancer by regulating the PI3K/AKT and MAPK pathways.

Authors:  Xiao Li; Caixia Wang; Shuang Wang; Yuexin Hu; Shan Jin; Ouxuan Liu; Rui Gou; Xin Nie; Juanjuan Liu; Bei Lin
Journal:  Cancer Cell Int       Date:  2021-06-09       Impact factor: 5.722

4.  Identification of key gene signatures for the overall survival of ovarian cancer.

Authors:  Akash Pawar; Oindrila Roy Chowdhury; Ruby Chauhan; Sanjay Talole; Atanu Bhattacharjee
Journal:  J Ovarian Res       Date:  2022-01-20       Impact factor: 4.234

5.  Predicting lymph node metastasis and prognosis of individual cancer patients based on miRNA-mediated RNA interactions.

Authors:  Shulei Ren; Wook Lee; Kyungsook Han
Journal:  BMC Med Genomics       Date:  2022-04-17       Impact factor: 3.622

6.  miR-29b-3p inhibits 22Rv1 prostate cancer cell proliferation through the YWHAE/BCL-2 regulatory axis.

Authors:  Jiafu Zhao; Xiaoyan Ma; Houqiang Xu
Journal:  Oncol Lett       Date:  2022-07-01       Impact factor: 3.111

Review 7.  The mechanobiome: a goldmine for cancer therapeutics.

Authors:  Eleana Parajón; Alexandra Surcel; Douglas N Robinson
Journal:  Am J Physiol Cell Physiol       Date:  2020-11-11       Impact factor: 4.249

8.  Development and Validation of a Robust Ferroptosis-Related Prognostic Signature in Lung Adenocarcinoma.

Authors:  Anran Zhang; Jinpo Yang; Chao Ma; Feng Li; Huan Luo
Journal:  Front Cell Dev Biol       Date:  2021-06-24

9.  Acquired Uniparental Disomy Regions Are Associated with Disease Outcome in Patients with Oral Cavity and Oropharynx But Not Larynx Cancers.

Authors:  Musaffe Tuna; Christopher I Amos; Gordon B Mills
Journal:  Transl Oncol       Date:  2020-04-15       Impact factor: 4.243

10.  Characterization of the expression and prognostic value of 14-3-3 isoforms in breast cancer.

Authors:  Jie Mei; Yan Liu; Rui Xu; Leiyu Hao; An Qin; Chunqiang Chu; Yichao Zhu; Xiao Liu
Journal:  Aging (Albany NY)       Date:  2020-10-14       Impact factor: 5.955

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.